What's happening
This bill requires practitioners to report any administration of naloxone or overdose reversal agents to the prescription monitoring program within 72 hours.
Why it matters
Creates a new requirement for healthcare providers to formally report all use of naloxone or similar overdose reversal drugs to the state's prescription monitoring program (PMP) within 72 hours. , which means overdose incidents are systematically tracked in the same system used to monitor controlled substance prescriptions.
Mandates that detailed patient information—such as name, address, date of birth, time/place of overdose intervention, and identity of the administering practitioner—be reported if available. , potentially improving the ability to identify individuals at high risk of repeated overdose and intervene proactively.
Explicitly frames the reporting as part of the provider’s official duties and as directly related to patient care. , offering some legal clarity and protection for practitioners and emphasizing the integration of overdose response into standard medical practice.
Could enhance public health surveillance and inform policy or interventions. by creating a more comprehensive dataset on overdose events, potentially supporting better resource allocation, early warning for overdose spikes, and targeted support for people at risk.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Report All Naloxone Uses
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 108
18 Co-sponsors
History
- Reported referred to codes
- Print number 2810b
- Amend (t) and recommit to health
- Print number 2810a
- Amend and recommit to health
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Report Naloxone Use to Registry
In Senate Committee · Health · Sponsor George Amedore
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
2810--B
2017-2018 Regular Sessions
IN ASSEMBLY
January 23, 2017
Introduced by M. of A. McDONALD, MOSLEY, GALEF, JOYNER, TITONE, MONTESA- NO, MORINELLO, CAHILL, GOTTFRIED, RAIA, WOERNER, LAWRENCE, BLAKE, B. MILLER, STECK, OTIS, PELLEGRINO -- Multi-Sponsored by -- M. of A. BLANKENBUSH, BRAUNSTEIN, GIGLIO, HOOPER, McDONOUGH,… Show allHide
Introduced by M. of A. McDONALD, MOSLEY, GALEF, JOYNER, TITONE, MONTESA- NO, MORINELLO, CAHILL, GOTTFRIED, RAIA, WOERNER, LAWRENCE, BLAKE, B. MILLER, STECK, OTIS, PELLEGRINO -- Multi-Sponsored by -- M. of A. BLANKENBUSH, BRAUNSTEIN, GIGLIO, HOOPER, McDONOUGH, SIMON, THIELE, WALSH -- read once and referred to the Committee on Health -- recommitted to the Committee on Health in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- again reported from said committee with amendments, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 9 of section 3343-a of the public health law is renumbered subdivision 10 and a new subdivision 9 is added to read as follows:
9. Administration of overdose reversal agents. (a) Any practitioner who administers naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose shall report the administration of the agent to the prescription monitoring program registry within seventy-two hours of administration. Such report shall contain the following information if available: (i) the name of the patient; (ii) the address of the patient; (iii) the date of birth of the patient; (iv) the time and place of the administration of the agent; and (v) the identity of the person who administered the naloxone to the patient.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07660-06-8
A. 2810--B 2
(b) Any report made pursuant to the terms of this subdivision shall be considered to be made by the reporter in the course of his or her duties and shall be directly related to patient care.
§ 2. This act shall take effect January 1, 2020.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.